Ensign Group (The) (ENSG) DIvidends Date & History

Key Takeaways

• The Ensign Group pays a quarterly dividend of $0.065 per share, translating to an annual dividend of $0.26 and a modest dividend yield of approximately 0.16%.
• The company has raised its dividend for 23 consecutive years, placing it among the most consistent dividend growers in the healthcare services industry.
• With a payout ratio of roughly 4.2%, the dividend is exceptionally well-covered by earnings and free cash flow, leaving ample room for future increases.
• ENSG's dividend yield is below the broader healthcare sector average but is supported by strong financials, including low debt levels and consistent free cash flow generation.
• The stock is best suited for long-term dividend growth investors rather than those seeking high current income.

Dividend Overview

ENSG, the parent company of The Ensign Group, Inc., operates skilled nursing facilities, senior living communities, and post-acute care services across the United States. The company pays a quarterly cash dividend, with the most recent quarterly distribution set at $0.065 per share. On an annualized basis, the dividend totals $0.26 per share, yielding approximately 0.16% at recent market prices. Dividends are typically declared in March, June, September, and December, with payment dates following roughly one month after each ex-dividend date. The most recent ex-dividend date was June 30, 2026, with a payment date of July 31, 2026. While the dividend yield is low compared to income-oriented stocks, Ensign is not positioned as a high-yield play. Rather, the company falls squarely into the dividend growth category — prioritizing steady, reliable increases over time rather than maximizing near-term distributions.

Dividend History and Growth

Ensign's dividend track record is one of the longest-running growth streaks in the healthcare provider space. The company has increased its dividend for 23 consecutive years, a milestone that reflects both disciplined capital allocation and consistent operational performance. Over the past five years, the dividend has grown at a compound annual growth rate (CAGR) of approximately 4.4%. Recent increases include a 4% hike announced in December 2025, which raised the quarterly payout from $0.0625 to $0.065 per share. Looking further back, the quarterly dividend has climbed steadily from $0.05 per share in 2019 to its current level — an increase of roughly 30% over that six-year window. Importantly, Ensign maintained and grew its dividend through the 2008–2009 financial crisis and the COVID-19 pandemic, periods during which many healthcare peers either cut or suspended their payouts. This resilience underscores the company's conservative dividend philosophy: modest payouts that can be sustained and increased through virtually any operating environment.

Dividend Sustainability and Payout Ratio

The cornerstone of Ensign's dividend safety is its exceptionally low payout ratio. Based on trailing twelve-month diluted earnings per share (EPS) of approximately $6.00 for fiscal 2025, the annual dividend of $0.26 per share represents a payout ratio of roughly 4.2%. This is dramatically below the healthcare sector average, which typically ranges from 30% to 40%. In terms of free cash flow (FCF), the dividend is equally well-covered. Ensign generated approximately $371 million in free cash flow during fiscal 2025, while total dividend payments amounted to roughly $14–15 million — a cash dividend payout ratio well under 5%. The company's balance sheet further reinforces dividend sustainability. As of the end of the third quarter of 2025, Ensign held $443.7 million in cash and cash equivalents against only $138.6 million in long-term debt. Its long-term debt-to-capital ratio of 6.1% is a fraction of the industry average, providing substantial financial flexibility. Even if earnings were to face temporary pressure, the wide gap between profits and dividend obligations gives management significant room to maintain — and continue growing — the payout.

Dividend Compared to Industry Peers

When measured against peers in the healthcare facilities and services sector, Ensign's dividend yield sits at the lower end of the spectrum. NHC (National HealthCare Corporation) offers a yield around 1.2%, while HCA (HCA Healthcare) yields approximately 0.84%. EHC (Encompass Health) yields roughly 0.68%, and UHS (Universal Health Services) pays a consistent $0.20 per share quarterly, yielding around 0.52%. Several major competitors, including THC (Tenet Healthcare) and ACHC (Acadia Healthcare), do not pay any dividend at all, focusing instead on share buybacks and reinvestment. Within this context, Ensign's 0.16% yield is modest but not an outlier. What distinguishes ENSG is the length of its dividend growth streak. No direct peer in the post-acute care and skilled nursing industry matches Ensign's 23-year track record of consecutive annual increases. For investors prioritizing reliability and consistency over current income, this record offers a meaningful point of differentiation.

AI Screener

For investors looking to identify dividend-paying stocks, growth opportunities, or breakout candidates across the healthcare sector and beyond, Tickeron's AI Screener offers a powerful, AI-driven discovery tool. The AI Screener enables users to filter thousands of stocks and ETFs using customizable criteria such as industry classification, market capitalization, technical indicators, price patterns, volatility metrics, and fundamental data. Whether you are screening for consistent dividend growers like Ensign, high-yield income stocks, or stocks exhibiting specific technical patterns, the AI Screener simplifies the research process by surfacing only the most relevant opportunities. It saves investors time by automating the market-scanning process, allowing for faster, data-driven decisions. Explore the AI Screener to uncover investment ideas aligned with your strategy.

Is This Stock Attractive for Dividend Investors?

Ensign Group is best characterized as a dividend growth stock rather than an income stock. With a yield of just 0.16%, it will not appeal to investors who rely on dividend income to meet living expenses or those seeking competitive yields in the current interest rate environment. Instead, the stock is likely to attract long-term, total-return-oriented investors who value dividend consistency, capital appreciation potential, and downside resilience. The 23-year dividend growth streak signals a management team deeply committed to returning capital to shareholders — but in a measured, sustainable way. The extremely low payout ratio means the dividend has abundant room to grow even if earnings growth moderates. For dividend growth investors who prioritize companies with durable competitive positions, strong balance sheets, and a proven willingness to raise dividends through economic cycles, ENSG presents a compelling profile. However, investors seeking higher current yields will find more attractive options elsewhere in the healthcare sector or in other dividend-oriented sectors altogether.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations